• MRT68921 ULK1 Kinase Inhibitor Workflow

  2026-09-02

  MRT68921 enables controlled blockade of autophagy initiation, making it useful for separating ULK-dependent effects from rapamycin-driven responses in lipid-stressed cells. This workflow connects ATG13 phosphorylation, LC3 flux measurement, lipidomics, and proteomics to practical assay decisions.

• Hydrocortisone Beyond the Bench: Designing Translation

  2026-09-01

  Hydrocortisone is more than a reference glucocorticoid hormone: it is a mechanistic probe and a translational design variable. This article connects receptor biology, inflammation and neuroprotection models, and PLGA-based corticosteroid delivery to help researchers build more predictive development strategies.

• AY 9944: From Sterol Control to Antiviral Insight

  2026-09-01

  DHCR7 is emerging as more than a cholesterol-biosynthesis enzyme. This thought-leadership guide connects AY 9944 dihydrochloride-based sterol perturbation with genetic evidence from GCRV-resistant grass carp, while outlining how translational researchers can separate validated biology from experimental opportunity.

• ATRX Loss Rewires RTK Inhibitor Sensitivity

  2026-08-31

  The reference study identifies ATRX deficiency as a potential determinant of sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data further support evaluating ATRX status when studying RTK inhibitor and temozolomide treatment strategies, while highlighting the need for genotype-aware interpretation of clinical trials.

• Pazopanib Hydrochloride: In Vitro Workflow

  2026-08-31

  Build more informative Pazopanib Hydrochloride experiments by separating growth inhibition from actual cell killing. This workflow combines dose-response design, time-resolved viability measurements, and angiogenesis-relevant assays to improve interpretation in cancer research.

• Cy5-UTP: Designing Better Fluorescent RNA Assays

  2026-08-30

  Cy5-UTP enables direct, far-red visualization of RNA generated by in vitro transcription. This guide connects Cyanine 5-uridine triphosphate chemistry with assay design for FISH, expression arrays, and RNA phase-separation studies.

• Cell Senescence β-Galactosidase Staining Kit Guide

  2026-08-29

  Build a practical SA-β-Gal workflow for fibroblast senescence models, senolytic screening, and frozen tissue analysis. This guide pairs the Cell Senescence β-Galactosidase Staining Kit with appropriate controls, quantitative scoring, and troubleshooting strategies for more reproducible senescent cell detection.

• Cinoxacin Workflows for Gram-Negative Research

  2026-08-28

  Cinoxacin is a quinolone antibiotic for structured susceptibility testing, urinary tract infection research, and Gram-negative pathogen profiling. This guide connects its concentration range, formulation limits, and organism selectivity to reproducible workflows, resistance experiments, and practical troubleshooting.

• Sulfo-Cy3 Azide for Aqueous Bioconjugation

  2026-08-28

  Sulfo-Cy3 azide is a water-soluble bioconjugation reagent for Click Chemistry fluorescent labeling of alkyne-bearing biomolecules. Its sulfonated structure supports aqueous workflows, while reported optical specifications include 563 nm excitation, 584 nm emission, and an extinction coefficient of 162,000 M⁻¹cm⁻¹.

• Foretinib (GSK1363089) Assay Workflows

  2026-08-27

  Build more informative Foretinib assays by separating growth arrest, cell death, and motility rather than relying on a single viability endpoint. This workflow connects ATP-competitive Met and VEGFR pathway inhibition to tumor cell growth inhibition, migration studies, and translational cancer metastasis models.

• N1-Methyl-Pseudouridine-5'-Triphosphate for mRNA

  2026-08-27

  N1-Methyl-Pseudouridine-5'-Triphosphate enables a controlled route to more stable, efficiently translated RNA for mechanistic assays and mRNA vaccine development. This guide connects modified-nucleotide synthesis with lipid nanoparticle studies, emphasizing matched controls, practical workflows, and troubleshooting rather than assuming that chemistry alone determines in vivo performance.

• MHY1485: A Practical mTOR Activator Workflow

  2026-08-26

  MHY1485 enables controlled mTOR pathway activation while suppressing autophagosome–lysosome fusion, making it useful for mechanistic autophagy assays, survival studies, and ovarian follicle development research. This guide translates its product specifications and the reference study’s contrasting lipid-signaling findings into practical workflows, controls, and troubleshooting strategies.

• CCT007093: From PPM1D Biology to Translation

  2026-08-26

  A translational perspective on CCT007093 as a PPM1D inhibitor, connecting p38 MAPK signaling, cancer-cell responses, and renal pyroptosis while outlining rigorous experimental strategies and the limits of current evidence.

• Hydroxytyrosol N2302 for Reliable Cell Assays

  2026-08-25

  Learn how Hydroxytyrosol, supplied as SKU N2302, can help researchers distinguish true biological protection from assay-specific signal changes in viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers solvent compatibility, preparation, storage, data interpretation, and practical reagent selection.

• SERCA2–CaN/FoxO1/FABP4 Axis in Atherosclerosis

  2026-08-25

  A 2025 British Journal of Pharmacology study links SERCA2 C674 dysfunction to calcineurin/FoxO1-driven induction of FABP4, abnormal fatty acid handling, macrophage foam cell formation, and atherosclerosis. Its use of genetic and pharmacological perturbations positions FABP4 inhibition as a mechanistic strategy for testing how calcium-handling defects reshape macrophage lipid metabolism.

8364 records 3/558 page Previous Next 12345 下5页 Last page